Autologous hinge as a universal antibody lock enhance the selectivity and safety of antibody drug

Авторы

  • Yun-Chi LU Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan
  • ian-Lu CHENG Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan
  • Chih-Hung CHUANG Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan
  • Wen-Wei LIN Department of Laboratory Medicine, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan

Ключевые слова:

on-target toxicities, “antibody lock”, Remicade

Аннотация

Autologous hinge as a universal antibody lock enhance the selectivity and safety of antibody drug

Биографии авторов

ian-Lu CHENG, Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Department of Biomedical Science and Environmental Biology, Kaohsiung Medical University, Kaohsiung, Taiwan

Professor, Director

Chih-Hung CHUANG, Department of Medical Laboratory Science and Biotechnology, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan

Assistant Professor

Загрузки

Опубликован

2019-07-17

Как цитировать

LU, Y.-C., CHENG, ian-L., CHUANG, C.-H., & LIN, W.-W. (2019). Autologous hinge as a universal antibody lock enhance the selectivity and safety of antibody drug. Вестник Дальневосточного отделения Российской академии наук, (6s), 114. извлечено от http://vestnikdvo.ru/index.php/vestnikdvo/article/view/353

Выпуск

№ 6s (2018): 6 Supplement

Раздел

Статьи